nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLC22A8—choroid plexus—brain cancer	0.0297	0.0782	CbGeAlD
Dinoprostone—HPGDS—ganglion—brain cancer	0.0121	0.0318	CbGeAlD
Dinoprostone—SLCO1C1—ganglion—brain cancer	0.00987	0.026	CbGeAlD
Dinoprostone—PTGIR—endothelium—brain cancer	0.00848	0.0224	CbGeAlD
Dinoprostone—PTGIR—blood vessel—brain cancer	0.00782	0.0206	CbGeAlD
Dinoprostone—PTGIR—hindbrain—brain cancer	0.00746	0.0197	CbGeAlD
Dinoprostone—Epoprostenol—CYP2C9—brain cancer	0.00695	1	CrCbGaD
Dinoprostone—SLCO2B1—ganglion—brain cancer	0.00616	0.0162	CbGeAlD
Dinoprostone—SLC22A1—ganglion—brain cancer	0.00588	0.0155	CbGeAlD
Dinoprostone—SLC51B—endocrine gland—brain cancer	0.0055	0.0145	CbGeAlD
Dinoprostone—PTGER3—telencephalon—brain cancer	0.00539	0.0142	CbGeAlD
Dinoprostone—HPGDS—brainstem—brain cancer	0.00525	0.0138	CbGeAlD
Dinoprostone—SLC51A—gonad—brain cancer	0.00521	0.0138	CbGeAlD
Dinoprostone—Hearing impaired—Procarbazine—brain cancer	0.00503	0.025	CcSEcCtD
Dinoprostone—HPGDS—telencephalon—brain cancer	0.00466	0.0123	CbGeAlD
Dinoprostone—PTGIR—brainstem—brain cancer	0.00428	0.0113	CbGeAlD
Dinoprostone—PTGER4—endocrine gland—brain cancer	0.00401	0.0106	CbGeAlD
Dinoprostone—PTGER4—head—brain cancer	0.00396	0.0104	CbGeAlD
Dinoprostone—SLC51A—endocrine gland—brain cancer	0.00394	0.0104	CbGeAlD
Dinoprostone—SLC51A—head—brain cancer	0.00389	0.0103	CbGeAlD
Dinoprostone—HPGDS—gonad—brain cancer	0.00389	0.0102	CbGeAlD
Dinoprostone—Deafness—Procarbazine—brain cancer	0.00388	0.0193	CcSEcCtD
Dinoprostone—PTGER1—endocrine gland—brain cancer	0.00387	0.0102	CbGeAlD
Dinoprostone—PTGER1—head—brain cancer	0.00382	0.0101	CbGeAlD
Dinoprostone—SLCO1C1—telencephalon—brain cancer	0.00381	0.01	CbGeAlD
Dinoprostone—PTGIR—telencephalon—brain cancer	0.00379	0.01	CbGeAlD
Dinoprostone—HPGDS—medulla oblongata—brain cancer	0.00366	0.00965	CbGeAlD
Dinoprostone—PTGER4—central nervous system—brain cancer	0.00362	0.00954	CbGeAlD
Dinoprostone—SLC51A—central nervous system—brain cancer	0.00355	0.00937	CbGeAlD
Dinoprostone—PTGER1—central nervous system—brain cancer	0.00349	0.00921	CbGeAlD
Dinoprostone—PTGER3—endocrine gland—brain cancer	0.0034	0.00896	CbGeAlD
Dinoprostone—PTGER3—head—brain cancer	0.00335	0.00885	CbGeAlD
Dinoprostone—HPGDS—midbrain—brain cancer	0.00334	0.00882	CbGeAlD
Dinoprostone—HPGDS—spinal cord—brain cancer	0.00326	0.0086	CbGeAlD
Dinoprostone—PTGIR—gonad—brain cancer	0.00317	0.00835	CbGeAlD
Dinoprostone—SLCO1C1—pituitary gland—brain cancer	0.0031	0.00818	CbGeAlD
Dinoprostone—PTGER3—central nervous system—brain cancer	0.00306	0.00808	CbGeAlD
Dinoprostone—SLCO4A1—telencephalon—brain cancer	0.00305	0.00805	CbGeAlD
Dinoprostone—Hearing impaired—Temozolomide—brain cancer	0.00304	0.0151	CcSEcCtD
Dinoprostone—ABCC5—telencephalon—brain cancer	0.00303	0.008	CbGeAlD
Dinoprostone—HPGDS—endocrine gland—brain cancer	0.00294	0.00774	CbGeAlD
Dinoprostone—Sweating increased—Procarbazine—brain cancer	0.00292	0.0146	CcSEcCtD
Dinoprostone—HPGDS—head—brain cancer	0.0029	0.00765	CbGeAlD
Dinoprostone—Vaginal inflammation—Temozolomide—brain cancer	0.00289	0.0144	CcSEcCtD
Dinoprostone—PTGER4—brain—brain cancer	0.00287	0.00757	CbGeAlD
Dinoprostone—SLC51A—brain—brain cancer	0.00282	0.00744	CbGeAlD
Dinoprostone—SLCO3A1—gonad—brain cancer	0.0028	0.00737	CbGeAlD
Dinoprostone—CYP11A1—gonad—brain cancer	0.00274	0.00723	CbGeAlD
Dinoprostone—SLCO1C1—midbrain—brain cancer	0.00273	0.00721	CbGeAlD
Dinoprostone—Vaginal infection—Temozolomide—brain cancer	0.00273	0.0136	CcSEcCtD
Dinoprostone—SLCO3A1—pituitary gland—brain cancer	0.00273	0.00719	CbGeAlD
Dinoprostone—PTGFR—endocrine gland—brain cancer	0.00272	0.00716	CbGeAlD
Dinoprostone—SLCO2A1—pituitary gland—brain cancer	0.0027	0.00712	CbGeAlD
Dinoprostone—PTGFR—head—brain cancer	0.00268	0.00707	CbGeAlD
Dinoprostone—SLCO1C1—spinal cord—brain cancer	0.00267	0.00704	CbGeAlD
Dinoprostone—PTGIR—spinal cord—brain cancer	0.00266	0.00701	CbGeAlD
Dinoprostone—HPGDS—central nervous system—brain cancer	0.00265	0.00698	CbGeAlD
Dinoprostone—SLCO3A1—medulla oblongata—brain cancer	0.00263	0.00694	CbGeAlD
Dinoprostone—Pain—Carboplatin—brain cancer	0.00263	0.0131	CcSEcCtD
Dinoprostone—Chest discomfort—Etoposide—brain cancer	0.00262	0.013	CcSEcCtD
Dinoprostone—CYP11A1—medulla oblongata—brain cancer	0.00258	0.0068	CbGeAlD
Dinoprostone—Skin discolouration—Etoposide—brain cancer	0.00256	0.0128	CcSEcCtD
Dinoprostone—SLCO4A1—pituitary gland—brain cancer	0.00248	0.00655	CbGeAlD
Dinoprostone—ABCC5—pituitary gland—brain cancer	0.00247	0.00652	CbGeAlD
Dinoprostone—PTGER3—brain—brain cancer	0.00243	0.00641	CbGeAlD
Dinoprostone—Body temperature increased—Carboplatin—brain cancer	0.00243	0.0121	CcSEcCtD
Dinoprostone—Eye pain—Carmustine—brain cancer	0.00241	0.012	CcSEcCtD
Dinoprostone—SLCO3A1—midbrain—brain cancer	0.00241	0.00634	CbGeAlD
Dinoprostone—SLCO1C1—endocrine gland—brain cancer	0.0024	0.00633	CbGeAlD
Dinoprostone—SLCO4A1—medulla oblongata—brain cancer	0.0024	0.00632	CbGeAlD
Dinoprostone—PTGIR—endocrine gland—brain cancer	0.00239	0.00631	CbGeAlD
Dinoprostone—Inflammation—Etoposide—brain cancer	0.00239	0.0119	CcSEcCtD
Dinoprostone—ABCC5—medulla oblongata—brain cancer	0.00238	0.00629	CbGeAlD
Dinoprostone—SLCO2B1—telencephalon—brain cancer	0.00237	0.00626	CbGeAlD
Dinoprostone—SLCO1C1—head—brain cancer	0.00237	0.00625	CbGeAlD
Dinoprostone—PTGIR—head—brain cancer	0.00236	0.00623	CbGeAlD
Dinoprostone—Deafness—Temozolomide—brain cancer	0.00235	0.0117	CcSEcCtD
Dinoprostone—SLCO3A1—spinal cord—brain cancer	0.00235	0.00619	CbGeAlD
Dinoprostone—SLC22A11—endocrine gland—brain cancer	0.00233	0.00615	CbGeAlD
Dinoprostone—Eye pain—Temozolomide—brain cancer	0.00233	0.0116	CcSEcCtD
Dinoprostone—SLC22A7—endocrine gland—brain cancer	0.00228	0.00601	CbGeAlD
Dinoprostone—SLC22A1—telencephalon—brain cancer	0.00227	0.00599	CbGeAlD
Dinoprostone—Hot flush—Temozolomide—brain cancer	0.00225	0.0112	CcSEcCtD
Dinoprostone—Flushing—Procarbazine—brain cancer	0.00223	0.0111	CcSEcCtD
Dinoprostone—Menopausal symptoms—Temozolomide—brain cancer	0.00223	0.0111	CcSEcCtD
Dinoprostone—SLCO4A1—midbrain—brain cancer	0.00219	0.00578	CbGeAlD
Dinoprostone—SLCO1A2—telencephalon—brain cancer	0.00219	0.00576	CbGeAlD
Dinoprostone—ABCC5—midbrain—brain cancer	0.00218	0.00575	CbGeAlD
Dinoprostone—SLCO1C1—central nervous system—brain cancer	0.00216	0.00571	CbGeAlD
Dinoprostone—PTGIR—central nervous system—brain cancer	0.00216	0.00569	CbGeAlD
Dinoprostone—Chills—Procarbazine—brain cancer	0.00216	0.0107	CcSEcCtD
Dinoprostone—Arrhythmia—Procarbazine—brain cancer	0.00215	0.0107	CcSEcCtD
Dinoprostone—SLCO4A1—spinal cord—brain cancer	0.00214	0.00564	CbGeAlD
Dinoprostone—Body temperature increased—Lomustine—brain cancer	0.00213	0.0106	CcSEcCtD
Dinoprostone—SLCO3A1—endocrine gland—brain cancer	0.00211	0.00557	CbGeAlD
Dinoprostone—PTGIR—cerebellum—brain cancer	0.00211	0.00556	CbGeAlD
Dinoprostone—HPGDS—brain—brain cancer	0.0021	0.00554	CbGeAlD
Dinoprostone—SLCO2A1—endocrine gland—brain cancer	0.00209	0.00552	CbGeAlD
Dinoprostone—SLCO3A1—head—brain cancer	0.00209	0.0055	CbGeAlD
Dinoprostone—CYP11A1—endocrine gland—brain cancer	0.00207	0.00546	CbGeAlD
Dinoprostone—SLCO2A1—head—brain cancer	0.00207	0.00545	CbGeAlD
Dinoprostone—Tension—Procarbazine—brain cancer	0.00205	0.0102	CcSEcCtD
Dinoprostone—CYP11A1—head—brain cancer	0.00204	0.00539	CbGeAlD
Dinoprostone—Tremor—Procarbazine—brain cancer	0.00196	0.00976	CcSEcCtD
Dinoprostone—Dehydration—Temozolomide—brain cancer	0.00195	0.00972	CcSEcCtD
Dinoprostone—SLCO4A1—endocrine gland—brain cancer	0.00192	0.00508	CbGeAlD
Dinoprostone—SLCO3A1—central nervous system—brain cancer	0.0019	0.00502	CbGeAlD
Dinoprostone—SLCO4A1—head—brain cancer	0.0019	0.00501	CbGeAlD
Dinoprostone—SLCO2A1—central nervous system—brain cancer	0.00189	0.00497	CbGeAlD
Dinoprostone—Syncope—Procarbazine—brain cancer	0.00188	0.00934	CcSEcCtD
Dinoprostone—SLCO2B1—medulla oblongata—brain cancer	0.00187	0.00492	CbGeAlD
Dinoprostone—CYP11A1—central nervous system—brain cancer	0.00187	0.00492	CbGeAlD
Dinoprostone—SLCO3A1—cerebellum—brain cancer	0.00186	0.00491	CbGeAlD
Dinoprostone—Loss of consciousness—Procarbazine—brain cancer	0.00184	0.00915	CcSEcCtD
Dinoprostone—Cough—Procarbazine—brain cancer	0.00183	0.00909	CcSEcCtD
Dinoprostone—Hypertension—Procarbazine—brain cancer	0.00181	0.00899	CcSEcCtD
Dinoprostone—Myalgia—Procarbazine—brain cancer	0.00178	0.00887	CcSEcCtD
Dinoprostone—Arthralgia—Procarbazine—brain cancer	0.00178	0.00887	CcSEcCtD
Dinoprostone—CYP19A1—gonad—brain cancer	0.00178	0.00469	CbGeAlD
Dinoprostone—Sweating increased—Temozolomide—brain cancer	0.00177	0.0088	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Etoposide—brain cancer	0.00174	0.00865	CcSEcCtD
Dinoprostone—SLCO4A1—central nervous system—brain cancer	0.00173	0.00457	CbGeAlD
Dinoprostone—SLCO1C1—brain—brain cancer	0.00172	0.00453	CbGeAlD
Dinoprostone—SLCO1A2—medulla oblongata—brain cancer	0.00172	0.00453	CbGeAlD
Dinoprostone—PTGIR—brain—brain cancer	0.00171	0.00452	CbGeAlD
Dinoprostone—Vomiting—Lomustine—brain cancer	0.00171	0.00851	CcSEcCtD
Dinoprostone—SLCO4A1—cerebellum—brain cancer	0.0017	0.00447	CbGeAlD
Dinoprostone—SLCO1B1—endocrine gland—brain cancer	0.00169	0.00447	CbGeAlD
Dinoprostone—Angiopathy—Hydroxyurea—brain cancer	0.00169	0.0084	CcSEcCtD
Dinoprostone—ABCC5—cerebellum—brain cancer	0.00169	0.00445	CbGeAlD
Dinoprostone—Shock—Procarbazine—brain cancer	0.00168	0.00836	CcSEcCtD
Dinoprostone—Chills—Hydroxyurea—brain cancer	0.00167	0.00831	CcSEcCtD
Dinoprostone—Tachycardia—Procarbazine—brain cancer	0.00167	0.0083	CcSEcCtD
Dinoprostone—SLCO2B1—spinal cord—brain cancer	0.00166	0.00439	CbGeAlD
Dinoprostone—Hyperhidrosis—Procarbazine—brain cancer	0.00165	0.00822	CcSEcCtD
Dinoprostone—SLC22A7—brain—brain cancer	0.00163	0.0043	CbGeAlD
Dinoprostone—Cardiac arrest—Etoposide—brain cancer	0.0016	0.00796	CcSEcCtD
Dinoprostone—Nausea—Lomustine—brain cancer	0.0016	0.00795	CcSEcCtD
Dinoprostone—Hypotension—Procarbazine—brain cancer	0.0016	0.00794	CcSEcCtD
Dinoprostone—SLC22A6—brain—brain cancer	0.00157	0.00415	CbGeAlD
Dinoprostone—SLCO1A2—midbrain—brain cancer	0.00157	0.00414	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00156	0.00774	CcSEcCtD
Dinoprostone—Paraesthesia—Procarbazine—brain cancer	0.00153	0.00763	CcSEcCtD
Dinoprostone—SLCO1A2—spinal cord—brain cancer	0.00153	0.00404	CbGeAlD
Dinoprostone—Cramp muscle—Etoposide—brain cancer	0.00151	0.00754	CcSEcCtD
Dinoprostone—SLCO3A1—brain—brain cancer	0.00151	0.00399	CbGeAlD
Dinoprostone—SLCO2B1—endocrine gland—brain cancer	0.0015	0.00395	CbGeAlD
Dinoprostone—SLCO2A1—brain—brain cancer	0.0015	0.00395	CbGeAlD
Dinoprostone—CYP11A1—brain—brain cancer	0.00148	0.00391	CbGeAlD
Dinoprostone—SLCO2B1—head—brain cancer	0.00148	0.0039	CbGeAlD
Dinoprostone—Pain—Procarbazine—brain cancer	0.00146	0.00727	CcSEcCtD
Dinoprostone—Pharyngitis—Temozolomide—brain cancer	0.00144	0.00718	CcSEcCtD
Dinoprostone—SLC22A1—endocrine gland—brain cancer	0.00143	0.00378	CbGeAlD
Dinoprostone—Bronchospasm—Etoposide—brain cancer	0.00143	0.00711	CcSEcCtD
Dinoprostone—Sweating increased—Etoposide—brain cancer	0.00141	0.00704	CcSEcCtD
Dinoprostone—SLC22A1—head—brain cancer	0.00141	0.00373	CbGeAlD
Dinoprostone—Gastrointestinal pain—Procarbazine—brain cancer	0.0014	0.00695	CcSEcCtD
Dinoprostone—Flushing—Carmustine—brain cancer	0.0014	0.00695	CcSEcCtD
Dinoprostone—SLCO1A2—endocrine gland—brain cancer	0.00138	0.00364	CbGeAlD
Dinoprostone—SLCO4A1—brain—brain cancer	0.00138	0.00363	CbGeAlD
Dinoprostone—ABCC5—brain—brain cancer	0.00137	0.00361	CbGeAlD
Dinoprostone—SLCO1A2—head—brain cancer	0.00136	0.00359	CbGeAlD
Dinoprostone—Abdominal pain—Procarbazine—brain cancer	0.00135	0.00672	CcSEcCtD
Dinoprostone—Body temperature increased—Procarbazine—brain cancer	0.00135	0.00672	CcSEcCtD
Dinoprostone—SLCO2B1—central nervous system—brain cancer	0.00135	0.00356	CbGeAlD
Dinoprostone—Flushing—Temozolomide—brain cancer	0.00135	0.00671	CcSEcCtD
Dinoprostone—CYP19A1—endocrine gland—brain cancer	0.00135	0.00355	CbGeAlD
Dinoprostone—Arrhythmia—Carmustine—brain cancer	0.00134	0.00669	CcSEcCtD
Dinoprostone—CYP19A1—head—brain cancer	0.00133	0.0035	CbGeAlD
Dinoprostone—ABCC4—endocrine gland—brain cancer	0.00133	0.0035	CbGeAlD
Dinoprostone—SLCO2B1—cerebellum—brain cancer	0.00132	0.00348	CbGeAlD
Dinoprostone—Angiopathy—Temozolomide—brain cancer	0.00132	0.00656	CcSEcCtD
Dinoprostone—Immune system disorder—Temozolomide—brain cancer	0.00131	0.00653	CcSEcCtD
Dinoprostone—ABCC4—head—brain cancer	0.00131	0.00345	CbGeAlD
Dinoprostone—Chills—Temozolomide—brain cancer	0.0013	0.00649	CcSEcCtD
Dinoprostone—SLC22A8—head—brain cancer	0.0013	0.00343	CbGeAlD
Dinoprostone—SLC22A1—central nervous system—brain cancer	0.00129	0.0034	CbGeAlD
Dinoprostone—Acute coronary syndrome—Etoposide—brain cancer	0.00128	0.00636	CcSEcCtD
Dinoprostone—Myocardial infarction—Etoposide—brain cancer	0.00127	0.00632	CcSEcCtD
Dinoprostone—Back pain—Carmustine—brain cancer	0.00127	0.0063	CcSEcCtD
Dinoprostone—Hypersensitivity—Procarbazine—brain cancer	0.00126	0.00626	CcSEcCtD
Dinoprostone—SLCO1A2—central nervous system—brain cancer	0.00124	0.00328	CbGeAlD
Dinoprostone—Vision blurred—Carmustine—brain cancer	0.00123	0.00614	CcSEcCtD
Dinoprostone—Tremor—Carmustine—brain cancer	0.00123	0.00611	CcSEcCtD
Dinoprostone—Asthenia—Procarbazine—brain cancer	0.00122	0.0061	CcSEcCtD
Dinoprostone—Back pain—Temozolomide—brain cancer	0.00122	0.00609	CcSEcCtD
Dinoprostone—SLCO1A2—cerebellum—brain cancer	0.00121	0.0032	CbGeAlD
Dinoprostone—CYP19A1—central nervous system—brain cancer	0.00121	0.0032	CbGeAlD
Dinoprostone—ABCC4—central nervous system—brain cancer	0.0012	0.00315	CbGeAlD
Dinoprostone—Vision blurred—Temozolomide—brain cancer	0.00119	0.00594	CcSEcCtD
Dinoprostone—SLC22A8—central nervous system—brain cancer	0.00119	0.00313	CbGeAlD
Dinoprostone—Tremor—Temozolomide—brain cancer	0.00118	0.0059	CcSEcCtD
Dinoprostone—Dyspnoea—Hydroxyurea—brain cancer	0.00118	0.00587	CcSEcCtD
Dinoprostone—Diarrhoea—Procarbazine—brain cancer	0.00117	0.00582	CcSEcCtD
Dinoprostone—Hypertension—Carmustine—brain cancer	0.00113	0.00563	CcSEcCtD
Dinoprostone—Pain—Hydroxyurea—brain cancer	0.00113	0.00563	CcSEcCtD
Dinoprostone—Dizziness—Procarbazine—brain cancer	0.00113	0.00562	CcSEcCtD
Dinoprostone—Chest pain—Carmustine—brain cancer	0.00111	0.00555	CcSEcCtD
Dinoprostone—Myalgia—Carmustine—brain cancer	0.00111	0.00555	CcSEcCtD
Dinoprostone—Cough—Temozolomide—brain cancer	0.0011	0.0055	CcSEcCtD
Dinoprostone—Hypertension—Temozolomide—brain cancer	0.00109	0.00544	CcSEcCtD
Dinoprostone—Vomiting—Procarbazine—brain cancer	0.00109	0.0054	CcSEcCtD
Dinoprostone—Flushing—Etoposide—brain cancer	0.00108	0.00537	CcSEcCtD
Dinoprostone—Myalgia—Temozolomide—brain cancer	0.00108	0.00536	CcSEcCtD
Dinoprostone—Arthralgia—Temozolomide—brain cancer	0.00108	0.00536	CcSEcCtD
Dinoprostone—Rash—Procarbazine—brain cancer	0.00108	0.00536	CcSEcCtD
Dinoprostone—Dermatitis—Procarbazine—brain cancer	0.00108	0.00535	CcSEcCtD
Dinoprostone—SLCO2B1—brain—brain cancer	0.00107	0.00283	CbGeAlD
Dinoprostone—Headache—Procarbazine—brain cancer	0.00107	0.00533	CcSEcCtD
Dinoprostone—Angiopathy—Etoposide—brain cancer	0.00105	0.00525	CcSEcCtD
Dinoprostone—Immune system disorder—Etoposide—brain cancer	0.00105	0.00523	CcSEcCtD
Dinoprostone—Body temperature increased—Hydroxyurea—brain cancer	0.00104	0.0052	CcSEcCtD
Dinoprostone—Chills—Etoposide—brain cancer	0.00104	0.00519	CcSEcCtD
Dinoprostone—Tachycardia—Carmustine—brain cancer	0.00104	0.00519	CcSEcCtD
Dinoprostone—Anaphylactic shock—Temozolomide—brain cancer	0.00103	0.00514	CcSEcCtD
Dinoprostone—SLC22A1—brain—brain cancer	0.00102	0.0027	CbGeAlD
Dinoprostone—Nausea—Procarbazine—brain cancer	0.00101	0.00505	CcSEcCtD
Dinoprostone—Hypotension—Carmustine—brain cancer	0.000998	0.00497	CcSEcCtD
Dinoprostone—Hyperhidrosis—Temozolomide—brain cancer	0.000998	0.00497	CcSEcCtD
Dinoprostone—SLCO1A2—brain—brain cancer	0.000986	0.0026	CbGeAlD
Dinoprostone—Back pain—Etoposide—brain cancer	0.000979	0.00487	CcSEcCtD
Dinoprostone—Hypersensitivity—Hydroxyurea—brain cancer	0.000974	0.00485	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000973	0.00485	CcSEcCtD
Dinoprostone—Muscle spasms—Etoposide—brain cancer	0.000973	0.00484	CcSEcCtD
Dinoprostone—CYP19A1—brain—brain cancer	0.000962	0.00254	CbGeAlD
Dinoprostone—Paraesthesia—Carmustine—brain cancer	0.000959	0.00478	CcSEcCtD
Dinoprostone—Dyspnoea—Carmustine—brain cancer	0.000952	0.00474	CcSEcCtD
Dinoprostone—ABCC4—brain—brain cancer	0.000949	0.0025	CbGeAlD
Dinoprostone—Asthenia—Hydroxyurea—brain cancer	0.000948	0.00472	CcSEcCtD
Dinoprostone—SLC22A8—brain—brain cancer	0.000941	0.00248	CbGeAlD
Dinoprostone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00094	0.00468	CcSEcCtD
Dinoprostone—Paraesthesia—Temozolomide—brain cancer	0.000927	0.00462	CcSEcCtD
Dinoprostone—Dyspnoea—Temozolomide—brain cancer	0.00092	0.00458	CcSEcCtD
Dinoprostone—Pain—Carmustine—brain cancer	0.000913	0.00455	CcSEcCtD
Dinoprostone—Diarrhoea—Hydroxyurea—brain cancer	0.000904	0.0045	CcSEcCtD
Dinoprostone—CYP1A2—endocrine gland—brain cancer	0.000901	0.00238	CbGeAlD
Dinoprostone—Loss of consciousness—Etoposide—brain cancer	0.00089	0.00443	CcSEcCtD
Dinoprostone—Cough—Etoposide—brain cancer	0.000883	0.0044	CcSEcCtD
Dinoprostone—Pain—Temozolomide—brain cancer	0.000883	0.0044	CcSEcCtD
Dinoprostone—Hypertension—Etoposide—brain cancer	0.000874	0.00435	CcSEcCtD
Dinoprostone—Dizziness—Hydroxyurea—brain cancer	0.000874	0.00435	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Carmustine—brain cancer	0.000873	0.00435	CcSEcCtD
Dinoprostone—Chest pain—Etoposide—brain cancer	0.000862	0.00429	CcSEcCtD
Dinoprostone—Body temperature increased—Carmustine—brain cancer	0.000844	0.0042	CcSEcCtD
Dinoprostone—Abdominal pain—Carmustine—brain cancer	0.000844	0.0042	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Temozolomide—brain cancer	0.000844	0.0042	CcSEcCtD
Dinoprostone—Vomiting—Hydroxyurea—brain cancer	0.00084	0.00418	CcSEcCtD
Dinoprostone—Rash—Hydroxyurea—brain cancer	0.000833	0.00415	CcSEcCtD
Dinoprostone—Dermatitis—Hydroxyurea—brain cancer	0.000832	0.00414	CcSEcCtD
Dinoprostone—Headache—Hydroxyurea—brain cancer	0.000828	0.00412	CcSEcCtD
Dinoprostone—Anaphylactic shock—Etoposide—brain cancer	0.000826	0.00411	CcSEcCtD
Dinoprostone—Body temperature increased—Temozolomide—brain cancer	0.000816	0.00406	CcSEcCtD
Dinoprostone—Abdominal pain—Temozolomide—brain cancer	0.000816	0.00406	CcSEcCtD
Dinoprostone—Tachycardia—Etoposide—brain cancer	0.000806	0.00401	CcSEcCtD
Dinoprostone—Hyperhidrosis—Etoposide—brain cancer	0.000799	0.00398	CcSEcCtD
Dinoprostone—Hypersensitivity—Carmustine—brain cancer	0.000787	0.00392	CcSEcCtD
Dinoprostone—Nausea—Hydroxyurea—brain cancer	0.000785	0.00391	CcSEcCtD
Dinoprostone—Hypotension—Etoposide—brain cancer	0.000772	0.00384	CcSEcCtD
Dinoprostone—Asthenia—Carmustine—brain cancer	0.000766	0.00382	CcSEcCtD
Dinoprostone—Hypersensitivity—Temozolomide—brain cancer	0.000761	0.00379	CcSEcCtD
Dinoprostone—Paraesthesia—Etoposide—brain cancer	0.000742	0.00369	CcSEcCtD
Dinoprostone—Asthenia—Temozolomide—brain cancer	0.000741	0.00369	CcSEcCtD
Dinoprostone—Dyspnoea—Etoposide—brain cancer	0.000736	0.00367	CcSEcCtD
Dinoprostone—Diarrhoea—Carmustine—brain cancer	0.000731	0.00364	CcSEcCtD
Dinoprostone—Dizziness—Carmustine—brain cancer	0.000706	0.00352	CcSEcCtD
Dinoprostone—Pain—Etoposide—brain cancer	0.000706	0.00352	CcSEcCtD
Dinoprostone—Diarrhoea—Temozolomide—brain cancer	0.000706	0.00352	CcSEcCtD
Dinoprostone—Dizziness—Temozolomide—brain cancer	0.000683	0.0034	CcSEcCtD
Dinoprostone—Vomiting—Carmustine—brain cancer	0.000679	0.00338	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—brain cancer	0.000675	0.00336	CcSEcCtD
Dinoprostone—Rash—Carmustine—brain cancer	0.000673	0.00335	CcSEcCtD
Dinoprostone—Dermatitis—Carmustine—brain cancer	0.000673	0.00335	CcSEcCtD
Dinoprostone—Headache—Carmustine—brain cancer	0.000669	0.00333	CcSEcCtD
Dinoprostone—Vomiting—Temozolomide—brain cancer	0.000656	0.00327	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—brain cancer	0.000653	0.00325	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—brain cancer	0.000653	0.00325	CcSEcCtD
Dinoprostone—Rash—Temozolomide—brain cancer	0.000651	0.00324	CcSEcCtD
Dinoprostone—Dermatitis—Temozolomide—brain cancer	0.00065	0.00324	CcSEcCtD
Dinoprostone—Headache—Temozolomide—brain cancer	0.000647	0.00322	CcSEcCtD
Dinoprostone—Nausea—Carmustine—brain cancer	0.000634	0.00316	CcSEcCtD
Dinoprostone—Nausea—Temozolomide—brain cancer	0.000613	0.00305	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—brain cancer	0.000609	0.00303	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—brain cancer	0.000593	0.00295	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—brain cancer	0.000565	0.00281	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—brain cancer	0.000546	0.00272	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—brain cancer	0.000525	0.00261	CcSEcCtD
Dinoprostone—Rash—Etoposide—brain cancer	0.000521	0.00259	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—brain cancer	0.00052	0.00259	CcSEcCtD
Dinoprostone—Headache—Etoposide—brain cancer	0.000517	0.00258	CcSEcCtD
Dinoprostone—Nausea—Etoposide—brain cancer	0.000491	0.00244	CcSEcCtD
Dinoprostone—PTGIR—GPCR downstream signaling—VAV1—brain cancer	0.000191	0.000461	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—VAV1—brain cancer	0.000191	0.000461	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SUFU—brain cancer	0.00019	0.000459	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—BSG—brain cancer	0.000187	0.000454	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TRPC6—brain cancer	0.000186	0.000451	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SUFU—brain cancer	0.000186	0.000449	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SUFU—brain cancer	0.000186	0.000449	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VAV1—brain cancer	0.000184	0.000446	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—IDH1—brain cancer	0.000184	0.000446	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PTCH1—brain cancer	0.000183	0.000444	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SMO—brain cancer	0.000183	0.000444	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GFAP—brain cancer	0.000183	0.000443	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000181	0.000438	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VAV1—brain cancer	0.00018	0.000435	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—PIK3CG—brain cancer	0.000179	0.000434	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GFAP—brain cancer	0.000179	0.000433	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GFAP—brain cancer	0.000179	0.000433	CbGpPWpGaD
Dinoprostone—ABCC4—Ectoderm Differentiation—MYC—brain cancer	0.000178	0.00043	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—VAV1—brain cancer	0.000177	0.000428	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SHH—brain cancer	0.000174	0.000421	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ENO2—brain cancer	0.000174	0.000421	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HEY1—brain cancer	0.000173	0.00042	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000173	0.000419	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—VAV1—brain cancer	0.000173	0.000419	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—VAV1—brain cancer	0.000173	0.000419	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000172	0.000417	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000171	0.000413	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—DLL1—brain cancer	0.00017	0.000411	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HEY1—brain cancer	0.00017	0.000411	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HEY1—brain cancer	0.00017	0.000411	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—DLL1—brain cancer	0.000166	0.000403	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—DLL1—brain cancer	0.000166	0.000403	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—PIK3CG—brain cancer	0.000165	0.0004	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000164	0.000398	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—PIK3CG—brain cancer	0.000163	0.000394	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP2C9—brain cancer	0.000162	0.000391	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—IDH1—brain cancer	0.000161	0.00039	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NOTCH2—brain cancer	0.000159	0.000384	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HES1—brain cancer	0.000158	0.000384	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000156	0.000377	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—IL2—brain cancer	0.000153	0.000372	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VAV1—brain cancer	0.000151	0.000366	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PDGFRA—brain cancer	0.000151	0.000365	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000151	0.000365	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00015	0.000364	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—PIK3CG—brain cancer	0.00015	0.000363	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000147	0.000356	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NOTCH2—brain cancer	0.000146	0.000355	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SPP1—brain cancer	0.000146	0.000355	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000146	0.000354	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ENO2—brain cancer	0.000145	0.000352	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SHH—brain cancer	0.000145	0.00035	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SHH—brain cancer	0.000141	0.000342	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SHH—brain cancer	0.000141	0.000342	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00014	0.00034	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VAV1—brain cancer	0.00014	0.000338	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL2—brain cancer	0.000139	0.000337	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TRPC6—brain cancer	0.000139	0.000337	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000138	0.000335	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP2C9—brain cancer	0.000138	0.000335	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—BSG—brain cancer	0.000137	0.000333	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMO—brain cancer	0.000137	0.000332	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTCH1—brain cancer	0.000137	0.000332	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TRPC6—brain cancer	0.000136	0.00033	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TRPC6—brain cancer	0.000136	0.00033	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000135	0.000328	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000135	0.000327	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—IL2—brain cancer	0.000135	0.000326	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTCH1—brain cancer	0.000134	0.000325	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMO—brain cancer	0.000134	0.000325	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMO—brain cancer	0.000134	0.000325	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTCH1—brain cancer	0.000134	0.000325	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IRS2—brain cancer	0.000132	0.000321	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000132	0.00032	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000132	0.00032	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000132	0.00032	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000131	0.000318	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HES1—brain cancer	0.00013	0.000315	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PIK3CG—brain cancer	0.000129	0.000312	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ENO2—brain cancer	0.000127	0.000308	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP2C9—brain cancer	0.000127	0.000307	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—IL2—brain cancer	0.000126	0.000305	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—VAV1—brain cancer	0.000126	0.000304	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—BSG—brain cancer	0.000124	0.000301	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000124	0.0003	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PDGFRA—brain cancer	0.000124	0.0003	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—PIK3CG—brain cancer	0.000124	0.000299	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—PIK3CG—brain cancer	0.000121	0.000293	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—PIK3CG—brain cancer	0.000121	0.000293	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SPP1—brain cancer	0.00012	0.000291	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HES1—brain cancer	0.00012	0.000291	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—IDH1—brain cancer	0.000118	0.000286	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP2C9—brain cancer	0.000118	0.000286	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—BSG—brain cancer	0.000117	0.000284	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—APC—brain cancer	0.000117	0.000283	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PIK3CG—brain cancer	0.000117	0.000283	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—IL2—brain cancer	0.000116	0.000282	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—VEGFA—brain cancer	0.000114	0.000277	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL2—brain cancer	0.000114	0.000277	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PDGFRA—brain cancer	0.000114	0.000277	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CG—brain cancer	0.000114	0.000276	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000114	0.000275	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CG—brain cancer	0.000112	0.000272	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SPP1—brain cancer	0.000111	0.000269	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CG—brain cancer	0.00011	0.000266	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CG—brain cancer	0.00011	0.000266	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOTCH2—brain cancer	0.00011	0.000265	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IRS2—brain cancer	0.000109	0.000263	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HES1—brain cancer	0.000108	0.000261	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—BSG—brain cancer	0.000108	0.000261	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOTCH2—brain cancer	0.000107	0.00026	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOTCH2—brain cancer	0.000107	0.00026	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—IDH1—brain cancer	0.000107	0.000259	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—EGFR—brain cancer	0.000107	0.000258	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL2—brain cancer	0.000106	0.000256	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VAV1—brain cancer	0.000104	0.000253	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PDGFRA—brain cancer	0.000103	0.000249	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VAV1—brain cancer	0.000102	0.000247	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VAV1—brain cancer	0.000102	0.000247	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—IDH1—brain cancer	0.000101	0.000245	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IRS2—brain cancer	0.0001	0.000243	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—BSG—brain cancer	0.0001	0.000243	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.62e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CG—brain cancer	9.61e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—APC—brain cancer	9.61e-05	0.000233	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ENO2—brain cancer	9.34e-05	0.000226	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—IDH1—brain cancer	9.26e-05	0.000224	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—RELA—brain cancer	9.14e-05	0.000221	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ERBB2—brain cancer	9.08e-05	0.00022	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.07e-05	0.000219	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IRS2—brain cancer	9.02e-05	0.000218	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HES1—brain cancer	8.98e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CG—brain cancer	8.87e-05	0.000215	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—APC—brain cancer	8.87e-05	0.000215	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HES1—brain cancer	8.79e-05	0.000213	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HES1—brain cancer	8.79e-05	0.000213	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—EGFR—brain cancer	8.75e-05	0.000212	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—IL2—brain cancer	8.7e-05	0.000211	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.7e-05	0.00021	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—brain cancer	8.65e-05	0.000209	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—IDH1—brain cancer	8.63e-05	0.000209	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PDGFRA—brain cancer	8.55e-05	0.000207	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—IL2—brain cancer	8.51e-05	0.000206	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—IL2—brain cancer	8.51e-05	0.000206	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ENO2—brain cancer	8.44e-05	0.000204	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PDGFRA—brain cancer	8.37e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PDGFRA—brain cancer	8.37e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SPP1—brain cancer	8.3e-05	0.000201	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL2—brain cancer	8.23e-05	0.000199	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.23e-05	0.000199	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SPP1—brain cancer	8.13e-05	0.000197	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SPP1—brain cancer	8.13e-05	0.000197	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—brain cancer	8.08e-05	0.000196	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IL2—brain cancer	8.03e-05	0.000194	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CCND1—brain cancer	8.03e-05	0.000194	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO2—brain cancer	7.99e-05	0.000193	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—APC—brain cancer	7.97e-05	0.000193	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CTNNB1—brain cancer	7.95e-05	0.000192	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL2—brain cancer	7.9e-05	0.000191	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL2—brain cancer	7.73e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL2—brain cancer	7.73e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—RELA—brain cancer	7.51e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IRS2—brain cancer	7.51e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB2—brain cancer	7.46e-05	0.000181	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IRS2—brain cancer	7.35e-05	0.000178	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IRS2—brain cancer	7.35e-05	0.000178	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO2—brain cancer	7.32e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—brain cancer	7e-05	0.000169	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—RELA—brain cancer	6.93e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—STAT3—brain cancer	6.93e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB2—brain cancer	6.88e-05	0.000167	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—brain cancer	6.82e-05	0.000165	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO2—brain cancer	6.82e-05	0.000165	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2—brain cancer	6.76e-05	0.000164	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CG—brain cancer	6.67e-05	0.000162	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—APC—brain cancer	6.63e-05	0.000161	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CG—brain cancer	6.63e-05	0.000161	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCND1—brain cancer	6.59e-05	0.00016	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CTNNB1—brain cancer	6.53e-05	0.000158	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CG—brain cancer	6.49e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—APC—brain cancer	6.49e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CG—brain cancer	6.49e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—APC—brain cancer	6.49e-05	0.000157	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—brain cancer	6.44e-05	0.000156	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—brain cancer	6.3e-05	0.000152	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2—brain cancer	6.24e-05	0.000151	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB2—brain cancer	6.19e-05	0.00015	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCND1—brain cancer	6.08e-05	0.000147	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—brain cancer	6.04e-05	0.000146	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CTNNB1—brain cancer	6.02e-05	0.000146	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—brain cancer	5.91e-05	0.000143	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—brain cancer	5.91e-05	0.000143	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CG—brain cancer	5.85e-05	0.000142	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—brain cancer	5.75e-05	0.000139	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—STAT3—brain cancer	5.69e-05	0.000138	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2C9—brain cancer	5.52e-05	0.000134	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—brain cancer	5.41e-05	0.000131	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—brain cancer	5.3e-05	0.000128	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—brain cancer	5.29e-05	0.000128	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—brain cancer	5.29e-05	0.000128	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—brain cancer	5.25e-05	0.000127	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RELA—brain cancer	5.18e-05	0.000125	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—brain cancer	5.17e-05	0.000125	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—brain cancer	5.16e-05	0.000125	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—brain cancer	5.15e-05	0.000125	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RELA—brain cancer	5.07e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RELA—brain cancer	5.07e-05	0.000123	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—brain cancer	5.04e-05	0.000122	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—brain cancer	5.04e-05	0.000122	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—brain cancer	4.88e-05	0.000118	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—brain cancer	4.77e-05	0.000116	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—brain cancer	4.72e-05	0.000114	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BSG—brain cancer	4.7e-05	0.000114	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—brain cancer	4.67e-05	0.000113	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—brain cancer	4.57e-05	0.000111	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—brain cancer	4.57e-05	0.000111	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—brain cancer	4.55e-05	0.00011	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—brain cancer	4.5e-05	0.000109	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—brain cancer	4.45e-05	0.000108	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—brain cancer	4.45e-05	0.000108	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—brain cancer	4.41e-05	0.000107	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—brain cancer	4.41e-05	0.000107	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—brain cancer	4.39e-05	0.000106	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—brain cancer	4.34e-05	0.000105	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—brain cancer	4.29e-05	0.000104	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—brain cancer	4.28e-05	0.000104	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH1—brain cancer	4.04e-05	9.77e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—brain cancer	4.01e-05	9.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—brain cancer	3.97e-05	9.6e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—brain cancer	3.93e-05	9.5e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—brain cancer	3.88e-05	9.4e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—brain cancer	3.88e-05	9.4e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—brain cancer	3.87e-05	9.37e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—brain cancer	3.84e-05	9.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—brain cancer	3.84e-05	9.3e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—brain cancer	3.66e-05	8.87e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—brain cancer	3.65e-05	8.83e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—brain cancer	3.57e-05	8.64e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—brain cancer	3.57e-05	8.64e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—brain cancer	3.57e-05	8.64e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—brain cancer	3.49e-05	8.46e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—brain cancer	3.49e-05	8.46e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—brain cancer	3.36e-05	8.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.29e-05	7.96e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO2—brain cancer	3.19e-05	7.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—brain cancer	3.13e-05	7.58e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—brain cancer	3e-05	7.25e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—brain cancer	2.93e-05	7.1e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—brain cancer	2.93e-05	7.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—brain cancer	1.46e-05	3.54e-05	CbGpPWpGaD
